Faes Farma, from Spain

Listed in:

Business: Pharmaceutical, Manufactures, Healthcare,

Auditor: KPMG.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 297.777 299.381 -0.54
Total Liabilities
78.979
102.413 -22.88
Equity
218.798
196.968 11.08
Working Capital
59.412
39.905 48.88
March 10, 2016

Basic Stock Information

Last Quote (EUR)
2.760
PER
28.70
Capitalization (Mns of EUR)
640.332
Capitalization/Equity
2.9266
Last month variation (%)
13.347
Last 3 months variation (%)
-1.429
Last 6 months variation (%)
15.481
Last 12 months variation (%)
30.806

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
96.334
93.470 3.06
EBIT
16.876
14.057 20.05
Net Profit
14.049
12.703 10.6
ROCE (%) 6.587 5.829 13.0
ROE 0.064 0.064 0.0
ROA 0.047 0.042 11.9
Net Profit over revenue 0.146 0.136 7.35
EBIT over revenue 0.175 0.150 16.67
EBITDA over revenue 0.224 0.212 5.66
Assets Rotation 0.324 0.312 3.85
Earning per share (EUR) 0.05977 0.05405 10.58

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 96.334 21.601 16.876 16.511 14.049 0.146 0.175 0.064 0.047 59.412 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 180.394 33.414 25.809 24.196 22.605 0.125 0.143 0.114 0.079 33.790 Details
H2 86.924 13.561 11.752 10.826 9.902 0.114 0.135 0.050 0.035 33.790 Details
H1 93.470 19.853 14.057 13.370 12.703 0.136 0.150 0.064 0.042 39.905 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 176.109 29.691 21.359 19.251 19.518 0.111 0.121 0.106 0.068 30.004 Details
H2 84.558 15.061 10.975 10.112 10.202 0.121 0.130 0.055 0.036 30.004 Details
H1 91.551 14.630 10.384 9.139 9.316 0.102 0.113 0.053 0.031 26.634 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 190.224 23.970 14.847 12.382 14.181 0.075 0.078 0.085 0.049 8.678 Details
H2 84.458 7.804 3.365 2.092 3.766 0.045 0.040 0.022 0.013 8.678 Details
H1 105.766 16.166 11.482 10.290 10.415 0.098 0.109 0.062 0.034 7.559 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 202.507 31.581 22.540 19.455 20.002 0.099 0.111 0.121 0.067 6.204 Details
H2 96.552 11.423 6.840 5.817 7.310 0.076 0.071 0.044 0.025 6.204 Details
H1 105.955 20.158 15.700 13.638 12.692 0.120 0.148 0.076 0.041 19.221 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 195.320 33.977 25.361 19.956 21.280 0.109 0.130 0.131 0.073 19.471 Details
H2 92.921 14.278 9.857 7.928 8.822 0.095 0.106 0.054 0.030 19.471 Details
H1 102.399 19.699 15.504 12.028 12.458 0.122 0.151 0.077 0.043 0.240 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 194.180 34.247 25.679 17.953 19.615 0.101 0.132 0.125 0.071 14.252 Details
H2 92.453 13.937 9.026 4.373 5.405 0.058 0.098 0.034 0.020 14.252 Details
H1 101.727 20.310 16.653 13.580 14.210 0.140 0.164 0.090 0.050 14.747 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (235043441) x (1 - 0.01293 ) x (2.760 EUR) = 640.332 Mns of EUR
  • PER: Last Quote (2.760 EUR) / Last annual earning per share (0.09617) = 28.699

News